Revolutionizing Point-of-Care Urine Diagnostics
UraSure™ integrates urine specimen collection and testing in a single patented device, reducing workflow steps, biomedical waste, and biohazard risks for healthcare professionals.
UraSure™ integrates urine specimen collection and testing in a single patented device, reducing workflow steps, biomedical waste, and biohazard risks for healthcare professionals.
UraSure™ is transforming urine diagnostics with its patented closed-system point-of-care platform (U.S. Patent No. 10,386,376). By combining collection and lateral flow testing into a single device, UraSure™ replaces three or more conventional components, eliminating the inefficiencies of traditional multi-step workflows seen in clinical settings worldwide.
Through advanced engineering, UraSure™ achieves up to 60% workflow reduction and cuts biomedical waste in half, all while providing a safer, more streamlined testing environment. With zero need for specimen transfer, the risk of biohazard exposure is eliminated, making UraSure™ a truly unique solution with no direct commercial equivalent. Our mission is to deliver safer, faster, and greener diagnostics to clinics and healthcare professionals everywhere.
UraSure™ is a patented diagnostic system that merges urine specimen collection and testing, streamlining point-of-care workflows for clinics and facilities.

UraSure's device integrates specimen collection and testing in a single use, closed system.

With no need for specimen transfer, UraSure™ ensures zero biohazard exposure for clinicians and technicians.

The platform reduces workflow times by 40-60% and eliminates 50% of biomedical waste.
At UraSure™, our mission is to revolutionize point-of-care urine diagnostics by merging safety, efficiency, and sustainability in a single, patented device. We aim to empower healthcare professionals with technology that makes diagnostics safer, simpler, and more environmentally responsible, setting new industry standards for patient and clinician well-being.
Learn More